AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-KAUG 66 min read$OMDA

Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Ch

Original reporting
SEC EDGAR 8-K
Published Aug 6, 2026, 8:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$OMDA
Bullish
medium confidence
Mentioned
$OMDA
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$OMDABullishHigh
01

Why it matters

Traders can reprice the stock based on raised revenue and adjusted EBITDA ranges plus margin expansion, while monitoring execution risk around leadership handoff and commercial rollout (including cholesterol management).

02

Market read

Raised FY 2026 revenue and adjusted EBITDA guidance, record gross margins, and a scheduled CEO transition create a fresh catalyst set for positioning into the next earnings cycle.

03

What to watch

The filing does not provide net loss outlook or GAAP-to-non-GAAP reconciliation, leaving uncertainty around GAAP profitability and warrant-related items.

Relevance 7/10Novelty 9/10Timing: after-hours filing and same-day conference call (Aug 6, 2026)

Background

Omada Health filed an 8-K with Q2 2026 operating results, an updated full-year outlook, and a planned CEO transition effective Jan 1, 2027.

Company-level read

Ticker impact

$OMDABullishMedium confidence
Context

Omada reported Q2 2026 results and raised full-year outlook, with revenue $88M (+43% YoY) and adjusted EBITDA $11M, plus CEO transition effective Jan 1, 2027.

Expected impact

Near-term bias to the upside on guidance/margin leverage, with volatility around the CEO transition narrative and any follow-through on 2027 revenue from new customers.

Evidence & confidence

The filing discloses fresh, decision-relevant datapoints: quarterly financials, raised FY revenue and adjusted EBITDA ranges, and a scheduled executive transition with defined roles and effective date.

Market effects

Sector

Improving margins and member growth in virtual care can support sentiment for digital health and chronic-care platforms, though impact is company-specific.

Regional

Primarily US-focused commercial expansion and PBM partnerships; limited direct regional spillover.

Global

Low global relevance beyond investor sentiment for US-listed digital health providers.

Counterpoint

What could challenge this read

Guidance strength may be partially driven by non-GAAP profitability and member growth that could face churn or reimbursement pressure, so upside may not persist.

Key entities

  • public_company
    Omada Health, Inc.

    Nasdaq-listed virtual between-visit healthcare provider reporting Q2 2026 results and raised FY 2026 outlook, with CEO transition planned for Jan 1, 2027.

  • executive
    Wei-Li Shao

    President becoming CEO effective Jan 1, 2027, responsible for strategy and operations.

  • executive
    Sean Duffy

    Co-founder and CEO transitioning to Founder and Executive Chair effective Jan 1, 2027.

  • executive
    Jeryl Hilleman

    Board Chairperson becoming Lead Independent Director and continuing as Audit Committee Chair effective Jan 1, 2027.

Read at source← All news

Related articles

AUG 13
$OMDAHighAI 9/10

Omada Health (OMDA) Q2 2026 Earnings Call Transcript

Omada Health (OMDA) reported Q2 2026 revenue of $88 million, up 43% year over year, with GAAP gross margin of 73% and GAAP net income of $5 million. Adjusted EBITDA was $11 million. The company raised full-year revenue guidance to $334 million to $340 million and adjusted EBITDA to $21 million to $27 million, citing member growth and lower cost to serve.

fool.com6 min
OCT 3
$NKEHighAI 8/10

Analyst warns Nike's best quarter this year may be behind it

Nike (NKE) reported Q1 earnings beating estimates, but investors sold shares. Morgan Stanley warns this may be the best quarter of the year, citing inventory risks and weaker forecasts. Nike expects fiscal 2027 revenue to decline by a high single-digit percentage. Analysts cut price targets, with Morgan Stanley suggesting a 50% drop in EPS over the next three quarters.

finance.yahoo.com3 min
OCT 3
$CCLHighAI 8/10

Carnival (CCL) Reports Strong Q3 Earnings, Dividend Sustainabili

Carnival Corporation (CCL) reported Q3 earnings of $1.43 per share, beating estimates by $0.08. The company offers a 1.56% dividend yield with a 19% payout ratio, and its stock is fairly valued at $25.76. CCL has a GF Score of 76, reflecting strengths in profitability and valuation but weaknesses in financial strength. Institutional investors show mixed sentiment, with 9 gurus increasing positions and 4 trimming them, while insiders sold $13.5 million in shares over the past year.

gurufocus.com2 min
OCT 3
$MUMedAI 8/10

Micron Just Extended Its Forecast for the AI Build-Out to 2031. Its Stock Is Bound to Defy History.

Micron Technology updated its forecast, stating that customer demand for memory chips will extend to 2031, up from 2030. The company reported Q4 fiscal 2027 revenue of $54.2 billion, up from $41.5 billion last quarter and $11.3 billion year-over-year. Micron projects $61.5 billion in revenue for the next quarter, citing strong AI-driven demand and supply constraints.

fool.com2 min